Clinical Trial: Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL




Official Title: Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Brief Summary: Post-marketing registration of Infliximab for injection in Chinese pediatric Crohn's disease patients.